Mr. Ron Nagar reports

TEMPRAMED EXPANDS INSTITUTIONAL HEALTH CARE NETWORK WITH MEUHEDET HEALTH SERVICES, A LEADING HMO IN ISRAEL, COVERING OVER 1 MILLION LIVES

Tempramed Technologies Ltd.'s flagship VIVI Cap and VIVI Epi products have been accepted by Meuhedet Health Services (Meuhedet), Israel's third-largest health maintenance organization (HMO), serving more than one million insured members nationwide.

Highlights

• Meuhedet Health Services, Israel's third-largest health maintenance organization, serving more than one million insured members, has accepted Tempramed's flagship VIVI Cap and VIVI Epi products.
• Tempramed products are now accepted by two of Israel's four national HMOs-Maccabi Healthcare services and Meuhedet -- providing institutional access to approximately four million insured lives.
• The company is executing a global B2B (business-to-business) institutional strategy focused on health care organizations, insurers, distributors and government health care systems.

The acceptance represents another significant milestone in Tempramed's institutional commercialization strategy, which is focused on driving adoption through health care organizations, insurers, payors, health care providers and government health systems rather than relying solely on traditional direct-to-consumer channels. Meuhedet operates an extensive health care network providing primary care, specialist care, diagnostics, pharmacy services, chronic disease management and digital health care solutions. Management believes its focus on innovation and integrated patient care aligns well with Tempramed's long-term vision for connected medication management through products such as VIVI Cap Smart, which combines temperature protection with medication adherence tracking and digital patient engagement.

"The acceptance by Meuhedet to offer our products represents another important milestone in executing our institutional health care strategy," said Ron Nagar, chief executive officer of Tempramed. "Our objective is to establish Tempramed as a global medical device provider for the safe storage of temperature-sensitive medications through health care systems, insurers, pharmacy networks and government organizations. We are executing on our institutional B2B strategy and are building a highly scalable commercial platform capable of reaching millions of patients through institutional health care channels. Our strategy is focused shifting towards working with enterprise-scale health care distributors that provide recurring revenue opportunities, improve patient access and support sustainable international growth."

Tempramed's commercialization strategy is centred on building long-term institutional relationships capable of delivering broad patient access, recurring product demand and reimbursement opportunities. The company has established commercial relationships across multiple health care channels, including HMOs, insurers, national pharmacy distributors, medical distributors, government organizations and retail pharmacy networks.

With this addition, Tempramed products have now been accepted by two of Israel's four national HMOs-Maccabi Healthcare Services and Meuhedet -- providing institutional access to approximately four million insured lives. Combined with the company working with Humana, one of the top five largest payors in the United States covering over 17 million lives, the company continues to see meaningful traction within the institutional health care market.

In addition to Meuhedet, Tempramed's combined commercial distribution network includes: Humana, MMS, Maccabi Healthcare Services, as well as national retail pharmacy and e-commerce platforms including Walgreens, Walmart, Amazon and Target.

About Meuhedet Health Services

Meuhedet Health Services is one of Israel's four national health maintenance organizations operating under Israel's National Health Insurance Law. Serving more than one million insured members nationwide, Meuhedet provides comprehensive health care services including primary care, specialty medicine, diagnostics, chronic disease management, pharmacy services, telemedicine and digital health care through an extensive national network of clinics and health care professionals.

About Tempramed Technologies Ltd.

Tempramed Technologies is a global medical technology company transforming the storage, protection and management of temperature-sensitive medications. The company's patented portfolio of Food and Drug Administration-registered thermal protection solutions safeguards insulin, GLP-1 therapies, biologics, epinephrine auto-injectors and other injectable medications without batteries, refrigeration or external power. Tempramed's commercial portfolio includes VIVI Cap, VIVI Cap Smart, VIVI Epi and VIVI Med, supporting both personal medication protection and connected medication management. The company is executing a global institutional commercialization strategy focused on health care organizations, insurers, pharmacy benefit managers, providers and distributors. Through strategic partnerships with leading health care organizations and retail pharmacy networks, Tempramed is working to expand patient access while advancing reimbursement pathways and building a scalable platform for recurring growth across the rapidly expanding market for temperature-sensitive medications.

We seek Safe Harbor.